fluorouracil and dinoprostone
fluorouracil has been researched along with dinoprostone in 30 studies
Research
Studies (30)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (6.67) | 18.7374 |
1990's | 3 (10.00) | 18.2507 |
2000's | 10 (33.33) | 29.6817 |
2010's | 11 (36.67) | 24.3611 |
2020's | 4 (13.33) | 2.80 |
Authors
Authors | Studies |
---|---|
Kobayashi, Y; Kohyama, N; Ohbayashi, M; Ohshiro, N; Tsuchiya, A; Yamamoto, T | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Lees, P; Sedgwick, AD | 1 |
Bradley, TR; Hodgson, GS; Kriegler, AB | 1 |
Fukumoto, M; Ishikawa, T; Kadokura, M; Okonogi, H; Sakaba, H; Shimizu, H; Suzuki, Y | 1 |
Hamuro, J; Kikuchi, T; Suzuki, M; Takatsuki, F | 1 |
ElAttar, TM; Virji, AS | 1 |
Half, E; Kuo, MT; Sinicrope, FA; Sun, Y; Tang, XM | 1 |
Evans, JF; Kargman, S; Kelly, CR; Kwong, E; Lam, EC; Luk, P; Wolfe, MM; Yao, M; Zheng, Y | 1 |
Cai, SH; Li, XH; Li, XK; Ren, XD; Tang, FX; Zhong, XY | 1 |
Hashitani, S; Maeda, T; Nishimura, N; Noguchi, K; Sakurai, K; Takaoka, K; Urade, M | 1 |
Breza, TS; Oberyszyn, TM; Tober, KL; Wilgus, TA | 1 |
Gouveris, P; Katsoulas, HL; Kosmas, C; Kosmas, N; Papalambros, E; Papantoniou, N; Rokana, S; Skopeliti, M; Tsavaris, NB; Tsitsilonis, OE | 1 |
Albert, A; Chang, AJ; Liu, TC; Sangha, S; Wolfe, MM; Yao, M; Zhou, W | 1 |
Kotani, T; Murashima, Y; Nakagiri, A; Takeuchi, K | 1 |
Adleff, V; Budai, B; Jeney, A; Kralovánszky, J; Pap, E; Réti, A | 1 |
Brazowski, E; Eisenthal, A; Eytan, K; Gitstein, G; Greenberg, R; Skornick, Y | 1 |
Hatano, H; Higashikawa, K; Kamata, N; Okui, G; Ono, S; Rizqiawan, A; Shigeishi, H; Tanaka, F; Tobiume, K; Tran, TT | 1 |
Cai, H; Cao, G; Chang, W; Ding, Y; Fu, C; Han, Y; Liu, Y; Ma, L; Su, T; Tan, X; Yu, Y; Zhang, H | 1 |
Guo, QL; Lu, ZJ; Sha, YY; Yao, J; You, QD; Zhao, L; Zhao, Q; Zhu, BB | 1 |
Bellamkonda, K; Sime, W; Sjölander, A | 1 |
Das, UN; Ni, X; Shen, S; Yu, H; Zhang, C | 1 |
Nakamura, K; Sasayama, A; Takahashi, T; Yamaji, T | 1 |
An, N; Chen, D; Fan, J; Li, J; Liu, C; Luo, J; Su, W; Wang, H; Zhao, J; Zhou, Y | 1 |
Assem, NZ; Duque, C; Ervolino, E; Ferro-Alves, ML; Garcia, VG; Longo, M; Louzada, LM; Theodoro, LH | 1 |
Cai, X; Chen, H; Cheng, J; Fan, Y; Fu, A; Huang, Y; Li, H; Li, M; Long, F; Nie, C; Shao, L; Yue, M; Zeng, H; Zhang, X; Zhu, Q | 1 |
Ma, H; Mao, R; Tang, Y; Yan, H; Zhang, Y; Zhao, Y | 1 |
Cao, L; Geng, L; Geng, S; Ren, X; Zhan, H | 1 |
Ao, H; Liu, D; Peng, C; Tang, F; Xu, LY; Zhang, JN; Zhang, L; Zhao, XL | 1 |
Other Studies
30 other study(ies) available for fluorouracil and dinoprostone
Article | Year |
---|---|
Renal transport of organic compounds mediated by mouse organic anion transporter 3 (mOat3): further substrate specificity of mOat3.
Topics: Allopurinol; Animals; Biological Transport; Dose-Response Relationship, Drug; Female; Kidney; Male; Mice; Oocytes; Organic Anion Transporters, Sodium-Independent; Substrate Specificity; Xenopus laevis | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Studies of eicosanoid production in the air pouch model of synovial inflammation.
Topics: 6-Ketoprostaglandin F1 alpha; Air; Animals; Carrageenan; Colchicine; Dinoprostone; Disease Models, Animal; Female; Fluorouracil; Inflammation; Kinetics; L-Lactate Dehydrogenase; Neutrophils; Pertussis Vaccine; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains; Synovial Fluid | 1986 |
The effect of prostaglandins E1 and E2 on macrophage progenitor cells with high proliferative potential in mouse bone marrow in vitro.
Topics: Alprostadil; Animals; Bone Marrow Cells; Cell Division; Dinoprostone; Fluorouracil; Humans; Macrophages; Male; Mice; Mice, Inbred BALB C; Prostaglandins E; Stem Cells | 1984 |
Effects of prostaglandin E2 on the micronucleus formation in mouse bone marrow cells by various mutagens.
Topics: 2-Naphthylamine; Animals; Benzo(a)pyrene; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Dimethylhydrazines; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Erythroblasts; Erythropoiesis; Erythropoietin; Fluorouracil; Male; Mice; Mice, Inbred BALB C; Micronucleus Tests; Mitomycin; Mutagens; Time Factors; Vincristine | 1994 |
Cancer cell progression and chemoimmunotherapy--dual effects in the induction of resistance to therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Avian Sarcoma Viruses; Combined Modality Therapy; Cyclophosphamide; Dinoprostone; Disease Progression; Drug Resistance, Neoplasm; Female; Fibrosarcoma; Fluorouracil; Immunotherapy; Interleukin-2; Lentinan; Mice; Mice, Inbred Strains; Transforming Growth Factor beta | 1996 |
Inhibition of growth in oral squamous carcinoma cells by cyclopentenone prostaglandins: comparison with chemotherapeutic agents.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Dinoprostone; Fluorouracil; Humans; Methotrexate; Mouth Neoplasms; Prostaglandin D2; Prostaglandins A; Prostaglandins A, Synthetic; Prostaglandins, Synthetic; Tocopherols; Tumor Cells, Cultured; Vitamin E | 1997 |
Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase Inhibitors; Caspases; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytochrome c Group; Dinoprostone; Enzyme Activation; Fluorouracil; Humans; Isoenzymes; Membrane Proteins; Mitochondria; Nitrobenzenes; Nucleic Acid Synthesis Inhibitors; Prostaglandin-Endoperoxide Synthases; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Sulfonamides; Transfection; Tumor Cells, Cultured | 2002 |
Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Camptothecin; Cell Division; Colorectal Neoplasms; Cyclin D1; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytoskeletal Proteins; Dinoprostone; Drug Synergism; Endothelial Growth Factors; Fluorouracil; Intercellular Signaling Peptides and Proteins; Interleukin-10; Interleukin-12; Irinotecan; Isoenzymes; Lactones; Liver Neoplasms, Experimental; Lymphokines; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Membrane Proteins; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Prostaglandin-Endoperoxide Synthases; Sulfones; Trans-Activators; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Synergistic effects of nimesulide and 5-fluorouracil on tumor growth and apoptosis in the implanted hepatoma in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Apoptosis; Cyclooxygenase Inhibitors; Dinoprostone; Drug Synergism; Fluorouracil; Liver Neoplasms, Experimental; Mice; Microscopy, Electron; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Sulfonamides; Tumor Suppressor Protein p53 | 2003 |
Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Bleomycin; Blotting, Western; Carcinoma; Celecoxib; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Fluorouracil; Head and Neck Neoplasms; Humans; Inhibitory Concentration 50; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Sulindac; Time Factors; Vincristine | 2003 |
Treatment with 5-fluorouracil and celecoxib displays synergistic regression of ultraviolet light B-induced skin tumors.
Topics: Administration, Topical; Animals; Antimetabolites, Antineoplastic; Celecoxib; Cell Division; Cyclooxygenase Inhibitors; Dinoprostone; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Mice; Mice, Hairless; Pyrazoles; Skin; Skin Neoplasms; Sulfonamides; Ultraviolet Rays | 2004 |
The effect of Edrecolomab (Mo17-1A) or fluorouracil-based chemotherapy on specific immune parameters in patients with colorectal cancer. A comparative study.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colorectal Neoplasms; Cytokines; Dinoprostone; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Fluorouracil; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferon-gamma; Interleukins; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukocytes, Mononuclear; Male; Middle Aged; Neoplasm Staging; Tumor Necrosis Factor-alpha | 2004 |
Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Camptothecin; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Fluorouracil; HT29 Cells; Humans; Ibuprofen; Irinotecan; Lactones; Liver Neoplasms; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Prostaglandin-Endoperoxide Synthases; Sulfones; Survival Analysis; Xenograft Model Antitumor Assays | 2005 |
Prophylactic effect of lafutidine against the adverse reaction induced in rat stomach by repeated administration of 5-fluorouracil.
Topics: Acetamides; Animals; Anti-Ulcer Agents; Cimetidine; Dinoprostone; Drug Interactions; Fluorouracil; Gastric Mucosa; Hydrochloric Acid; Male; Membrane Potentials; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Stomach; Stomach Ulcer; Taurocholic Acid | 2007 |
Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Collagen; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dihydrouracil Dehydrogenase (NADP); Dinoprostone; Down-Regulation; Drug Interactions; Extracellular Matrix; Fluorescent Antibody Technique; Fluorouracil; HT29 Cells; Humans; Indomethacin; Nitrobenzenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Xenograft Model Antitumor Assays | 2010 |
Effects of 5-FU on DNA synthesis and cytotoxicity of human lymphocytes induced by IL-2, TGF-beta3 and PGE2.
Topics: Cell Cycle; Cells, Cultured; Culture Media; Cytotoxicity, Immunologic; Dinoprostone; DNA; Drug Interactions; Fluorouracil; Humans; Interleukin-2; Lymphocyte Activation; Lymphocytes; Receptors, Interleukin-2; Thymidine; Transforming Growth Factor beta3 | 2009 |
PGE₂ targets squamous cell carcinoma cell with the activated epidermal growth factor receptor family for survival against 5-fluorouracil through NR4A2 induction.
Topics: Antineoplastic Agents; Base Sequence; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Dinoprostone; DNA Primers; ErbB Receptors; Fluorouracil; Humans; Nuclear Receptor Subfamily 4, Group A, Member 2; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Topics: Adenoma; Adenomatous Polyposis Coli; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Chemotherapy, Adjuvant; Chi-Square Distribution; Colorectal Neoplasms; Dinoprostone; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fluorouracil; HCT116 Cells; Humans; Intestinal Polyps; Kaplan-Meier Estimate; Leucovorin; Multivariate Analysis; Neoplasm Staging; Nuclear Receptor Subfamily 4, Group A, Member 2; Organoplatinum Compounds; Proportional Hazards Models; Time Factors; Transfection; Treatment Outcome; Up-Regulation | 2013 |
Enhanced 5-fluorouracil cytotoxicity in high COX-2 expressing hepatocellular carcinoma cells by wogonin via the PI3K/Akt pathway.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Drug Synergism; Female; Flavanones; Fluorouracil; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Plant Extracts; Proto-Oncogene Proteins c-akt; Signal Transduction | 2013 |
The impact of inflammatory lipid mediators on colon cancer-initiating cells.
Topics: Animals; Caco-2 Cells; Cell Line, Tumor; Colonic Neoplasms; Dinoprostone; Disease Progression; Drug Resistance, Neoplasm; Female; Fluorouracil; HCT116 Cells; HT29 Cells; Humans; Inflammation; Leukotriene D4; Lipids; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2015 |
Growth inhibitory effect of polyunsaturated fatty acids (PUFAs) on colon cancer cells via their growth inhibitory metabolites and fatty acid composition changes.
Topics: Antimetabolites, Antineoplastic; Arachidonate 5-Lipoxygenase; Cell Line, Tumor; Colorectal Neoplasms; Cyclooxygenase 2; Dinoprostone; Fatty Acids; Fatty Acids, Unsaturated; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Intramolecular Oxidoreductases; Leukotriene B4; Lipocalins; Lipoxins; Prostaglandin-E Synthases | 2015 |
An Immune-Modulating Diet in Combination with Chemotherapy Prevents Cancer Cachexia by Attenuating Systemic Inflammation in Colon 26 Tumor-Bearing Mice.
Topics: Animals; Antineoplastic Agents; Blood Glucose; Cachexia; Cell Line, Tumor; Colon; Colonic Neoplasms; Diet; Dinoprostone; Disease Models, Animal; Energy Intake; Fluorouracil; Immunologic Factors; Immunosuppressive Agents; Inflammation; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Muscle, Skeletal; Organ Size; Vascular Endothelial Growth Factor A | 2015 |
Oxytocin evokes a pulsatile PGE2 release from ileum mucosa and is required for repair of intestinal epithelium after injury.
Topics: Animals; Antineoplastic Agents; Calcium; Cyclooxygenase 2; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Evoked Potentials; Fluorouracil; Ileum; Immunohistochemistry; Indomethacin; Intestinal Diseases; Intestinal Mucosa; Ions; Male; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Neoplasms; Oxytocin; Rats; Rats, Wistar; Receptors, Oxytocin; Wound Healing; Xanthones | 2015 |
Effect of low-level laser therapy as an adjuvant in the treatment of periodontitis induced in rats subjected to 5-fluorouracil chemotherapy.
Topics: Alveolar Bone Loss; Animals; Bacteria; Caspase 3; Combined Modality Therapy; Dental Scaling; Dinoprostone; Drug Therapy; Fluorouracil; Inflammation; Interleukin-6; Low-Level Light Therapy; Male; Mandible; Molar; Osteoprotegerin; Periodontitis; RANK Ligand; Rats; Rats, Wistar; Root Planing; Tumor Necrosis Factor-alpha | 2016 |
Prostaglandin E2 accelerated recovery of chemotherapy-induced intestinal damage by increasing expression of cyclin D.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Proliferation; Cyclin D; Dinoprostone; Fluorouracil; Gene Expression Regulation; Humans; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Oxytocics; Stem Cells; Tumor Cells, Cultured | 2020 |
Sprayable NAHAO® hydrogel alleviates pain and accelerates rat oral mucositis wound healing.
Topics: Animals; Capsaicin; Cyclooxygenase 2; Dinoprostone; Fluorouracil; Humans; Hydrogels; Male; Matrix Metalloproteinase 9; Pain; Rats; Rats, Sprague-Dawley; Stomatitis; Wound Healing | 2023 |
Targeting PTGES/PGE2 axis enhances sensitivity of colorectal cancer cells to 5-fluorouracil.
Topics: Cell Line, Tumor; Colorectal Neoplasms; Dinoprostone; Drug Resistance, Neoplasm; Fluorouracil; Humans; Prostaglandin-E Synthases | 2023 |
Topics: Alpinia; Animals; Diarrhea; Dinoprostone; Fluorouracil; Gastrointestinal Microbiome; Mice; Mucositis; Oils, Volatile; Prostaglandin-E Synthases | 2023 |